Mercato chiuso -
Altri mercati azionari
|
Variaz. 5gg | Var. 1 gen. | ||
0,8378 USD | +4,09% | +1,92% | -11,57% |
Attività
Numero di dipendenti: 58
Vendite per attività
USD in Milioni | 2022 | Peso | 2023 | Peso | Delta |
---|---|---|---|---|---|
Immune-mediated Diseases and Cancer Therapeutics
100,0
%
| 0 | nan % | 7 | 100,0 % | - |
Vendite per regione
USD in Milioni | 2022 | Peso | 2023 | Peso | Delta |
---|---|---|---|---|---|
United States
100,0
%
| 0 | nan % | 7 | 100,0 % | - |
Dirigenti
Dirigenti | Titolo | Età | Da |
---|---|---|---|
Christopher Kirk
FOU | Founder | 52 | 19/02/15 |
John Fowler
FOU | Founder | 52 | 19/02/15 |
Marc Belsky
DFI | Director of Finance/CFO | 68 | 01/03/18 |
Gitanjali Jain
IRC | Investor Relations Contact | - | 05/10/21 |
Nick Mordwinkin
PRN | Corporate Officer/Principal | - | 11/07/22 |
Li Long
PRN | Corporate Officer/Principal | - | - |
Andrea Fan
PRN | Corporate Officer/Principal | - | 01/01/15 |
Jinhai Wang
PRN | Corporate Officer/Principal | - | - |
General Counsel | - | - | |
General Counsel | - | 01/04/19 |
Amministratori
Amministratori | Titolo | Età | Da |
---|---|---|---|
Franklin Berger
BRD | Director/Board Member | 74 | 01/11/16 |
Graham Cooper
CHM | Chairman | 54 | 01/10/17 |
Michael Kauffman
BRD | Director/Board Member | 60 | 01/12/16 |
John Fowler
FOU | Founder | 52 | 19/02/15 |
Christopher Kirk
FOU | Founder | 52 | 19/02/15 |
Elizabeth Garner
BRD | Director/Board Member | 56 | 18/12/19 |
Courtney Wallace
BRD | Director/Board Member | 40 | 09/12/21 |
Micki Klearman
BRD | Director/Board Member | 69 | 01/06/21 |
Classe di azioni
Voto | Quantità | Flottante | Autocontrollo | Flottante totale | |
---|---|---|---|---|---|
Azione A | 1 | 72 801 359 | 62 021 528 ( 85,19 %) | 0 | 85,19 % |
Coordinate società
Kezar Life Sciences, Inc.
4000 Shoreline Court Suite 300
94080, South San Francisco
+650 822 5600
http://www.kezarlifesciences.comSettore
Vendite per regione
Revisioni EPS
Variaz. 1 gen. | Capi. | |
---|---|---|
-11,57% | 60,99 Mln | |
-2,63% | 102 Mrd | |
+1,62% | 96,29 Mrd | |
+2,56% | 22,18 Mrd | |
-16,67% | 21,2 Mrd | |
-9,07% | 18,31 Mrd | |
-38,74% | 17,38 Mrd | |
-13,21% | 16,36 Mrd | |
+5,41% | 13,97 Mrd | |
+33,57% | 12,17 Mrd |
- Borsa valori
- Azioni
- Azione KZR
- Società Kezar Life Sciences, Inc.